1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow velsecorat: new trials by email Literature Review of velsecorat trials Research Report on velsecorat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma 800 μg AZD7594 once daily, 250 µg AZD7594 once daily, 58 µg AZD7594 once daily - Asthma, Efficacy | Phase 2 | Completed | AstraZeneca | 54 | 2015-06-25 | 2018-02-15 |
Asthma (1)
AstraZeneca (1)
Bulgaria (1) · Germany (1)
Andrea Ludwig-Sengpiel, Dr. (1) · Anne-Marie Kirsten, Dr. (1) · Anneliese Linnhoff, Dr. med. (1) · Christine Grigat, Dr. (1) · Dirk Skowasch, Prof. (1) · Jutta Beier, Dr. med. (1) · Margret Jandl, Dr. (1) · Oliver Kornmann, Dr. (1) · Rainard Fuhr, Dr. med. (1) · Tanya Kralimarkova, Dr. (1) · Ulrike Westerhausen, Dr. (1)
2014 (1)